Discussion about this post

User's avatar
Manoli Kulutbanis's avatar

A great write-up on David.

The Brand Lab's avatar

he David Protein story is the most interesting thing in CPG right now and nobody is asking the right question. The calorie lawsuit will probably fail on the science. The bomb calorimetry argument doesn't hold up against the FDA's own methodology. But the real story isn't whether the bar is 150 calories. It's whether building a $725M company on a single novel ingredient that one company manufactures, that you then acquired to lock out competitors, and that requires a paragraph of food science to explain why it's not what the lab says it is, constitutes a durable business or a regulatory arbitrage play with a shelf life. The product works until the FDA changes how it classifies EPG, or a competitor reverse engineers an alternative, or consumer trust erodes faster than the legal team can rebuild it. Peter Rahal built RXBAR on radical ingredient transparency. Three egg whites, two dates, no BS. David is built on the opposite: an ingredient so novel that the standard calorie test doesn't apply and you need a PhD to explain why the label is accurate. Both made money. Only one of those stories ages well if the regulatory environment shifts

No posts

Ready for more?